IQVIA (NYSE: IQV) — Perfil da empresa, notícias e dados financeiros
IQVIA provides advanced analytics and clinical research services to the global healthcare industry, improving patient outcomes.
IQVIA
IQVIA is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Formed through the merger of Quintiles and IMS Health, the company serves biopharmaceutical manufacturers, medical device firms, healthcare providers, and researchers. Its operations encompass clinical trial management across all development phases, healthcare data analytics, commercial strategy execution, real-world evidence generation, and regulatory compliance support. The company integrates large-scale medical data with proprietary technology platforms and domain expertise to assist healthcare organizations in accelerating clinical development, optimizing commercial operations, and evaluating drug safety and efficacy across international markets.
Resumo
Operações
Produtos e/ou serviços de IQVIA
- Research & Development Solutions: Phase I through IV clinical trial execution, study design, site selection, patient recruitment, and functional outsourcing services catering to biopharmaceutical and medical device manufacturers across global clinical research programs.
- Commercialization Services: Healthcare data analytics, market measurement insights, healthcare provider engagement, launch management, and sales force design, enabling biopharmaceutical companies to optimize brand performance and commercial strategies in international markets.
- Real World Solutions: Collection and analytics of real-world evidence utilizing healthcare data sets, patient registries, electronic health records, and natural language processing to evaluate post-market drug safety, clinical outcomes, and health economics.
- Technology & Analytics Platforms: Integrated software platforms and artificial intelligence applications for clinical data management, regulatory information systems, commercial compliance, and enterprise analytics, supporting operational workflows across global life sciences organizations.
- Safety & Regulatory Compliance: Global pharmacovigilance services, quality management systems, regulatory compliance consulting, and medical information reporting that help life sciences organizations meet international regulatory standards throughout the medical product lifecycle.
- Patient & Site Centric Solutions: Digital tools including electronic clinical outcome assessments, decentralized trial technologies, trial payment systems, and site administrative software designed to streamline trial administration and enhance participant retention in clinical studies.
equipe executiva do IQVIA
- Ari BousbibCEO & Chairman
- Eric M. SherbetExecutive VP, General Counsel & Secretary
- W. Richard Staub IIIPresident of Research & Development Solutions
- Alistair GrenfellPresident of Commercial Solutions
- Michael J. FedockExecutive VP & Chief Financial Officer
- James G. BerkshireExecutive Vice President of Global Infrastructure & Operations
- Keriann CherofskySenior VP, Corporate Controller & Chief Accounting Officer
- Jeffrey A. SpaederChief Medical & Scientific Officer
- Kerri JosephSenior VP of Investor Relations & Treasurer
- Duane SachsSenior Vice President of Corporate Development
Principais indicadores financeiros
Resultados divulgados pela IQVIA, em USD.
- Cap. de mercado
- 46,3 bi
- Receita (TTM)
- 17,3 bi
- P/L
- 34.2
- LPA (diluído, TTM)
- 8.2
- Dividend yield
- —
- Margem de lucro
- 8.1%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 16,3 bi | 2,2 bi | 1,4 bi | |
| 15,4 bi | 2,2 bi | 1,4 bi | |
| 15 bi | 2 bi | 1,4 bi | |
| 14,4 bi | 1,8 bi | 1,1 bi |